Stonepine Capital Management LLC 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 5:36 pm Purchase | 2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management LLC | 626,862 9.990% | 61,378 (+10.85%) | Filing |
| 2024-02-13 4:25 pm Purchase | 2023-12-31 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management LLC | 565,484 9.990% | 1,642 (+0.29%) | Filing |
| 2023-06-16 4:48 pm Purchase | 2023-06-09 | 13G | Aytu BioPharma, Inc. AYTU | Stonepine Capital Management LLC | 563,842 9.990% | 563,842 (New Position) | Filing |